Skip to main content
Rhön-Klinikum AG logo

Rhön-Klinikum AG — Investor Relations & Filings

Ticker · RHK ISIN · DE0007042301 LEI · 529900MVGMIVUDQY9E20 F Human health and social work activities
Open in API
Filings indexed 923 across all filing types
Latest filing 2024-12-11 Audit Report / Informat…
Country DE Germany
Listing F RHK

About Rhön-Klinikum AG

https://en.rhoen-klinikum-ag.com/index.…

Rhön-Klinikum AG is a large healthcare provider that operates a group of hospitals and clinics. The company offers a comprehensive range of medical services, including inpatient and outpatient care, diagnostics, as well as therapeutic and nursing services. It focuses on providing integrated, patient-centered care with a strong connection to universities and research institutions to quickly apply new findings for patient benefit. A key strategic focus is the development of its 'Campus conception,' an innovative model for integrated healthcare delivery. The company is part of the Asklepios Group, forming a large network for advanced medical care.

Recent filings

Filing Released Lang Actions
Ergänzung der Veröffentlichung vom 17.05.2024
Audit Report / Information Classification · 95% confidence The document is titled 'NACHTRAG ZUM BERICHT DES AUFSICHTSRATS' (Addendum to the Supervisory Board Report) concerning the Annual and Consolidated Financial Statements for the fiscal year ending 12/31/2023. It specifically addresses a correction to the auditor's (KPMG) confirmation note ('Testat') that was inadvertently shortened in the original Supervisory Board report presented at the AGM. Since this document is an official addendum correcting a detail within the annual reporting/governance structure related to the audit confirmation, it relates closely to the audit process and governance oversight. However, it is not the full Annual Report (10-K) nor the standalone Audit Report (AR). It is a specific correction/addendum related to the audit confirmation included in the annual reporting cycle. Given the options, it is a specific report related to governance and oversight following the audit, but the core content is correcting the auditor's confirmation related to the annual financial statements. Since it is a formal correction to the report presented to shareholders, and it deals with the auditor's confirmation, it aligns best with Audit Report / Information (AR) as it is directly correcting an audit-related statement, or potentially Governance Information (CGR). Given the explicit mention and correction of the 'Bestätigungsvermerk' (Auditor's Confirmation/Attestation), AR is the most precise fit for this type of correction, even though it's an addendum to the Supervisory Board report. FY 2023
2024-12-11 German
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Stimmrechtsmitteilung' (Voting Rights Notification) and explicitly mentions compliance with German securities law (§ 40 Abs. 1 WpHG). It details changes in share ownership and voting rights percentages for specific shareholders (AMR Holding GmbH, Z. große Broermann) in RHÖN-KLINIKUM AG. This type of mandatory disclosure regarding changes in significant shareholdings directly corresponds to the definition of Major Shareholding Notification.
2024-12-10 German
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Stimmrechtsmitteilung' (Voting Rights Notification) and explicitly mentions compliance with German securities law (§ 40 Abs. 1 WpHG). It details changes in share ownership and voting rights percentages for specific shareholders (AMR Holding GmbH, Z. große Broermann) in RHÖN-KLINIKUM AG. This type of mandatory disclosure regarding changes in significant shareholdings directly corresponds to the definition of Major Shareholding Notification.
2024-12-09 German
Befreiung nach 37 Abs. 1 und Abs. 2 WpUG i.V.m. 9 Satz 1 Nr. 1 WpUG-AngebVO von den Pflichten nach 35 Abs. 1 Satz 1, 35 Abs. 2 Satz 1 WpUG in Bezug auf die RHON-KLINIKUM Aktiengesellschaft
Major Shareholding Notification Classification · 99% confidence The document is a formal announcement published via EQS-News concerning a decision by the German Federal Financial Supervisory Authority (BaFin). The content explicitly discusses an exemption ('Befreiung') granted under specific sections of the German Securities Trading Act (WpÜG), specifically § 37 WpÜG, related to mandatory takeover bids and disclosure obligations following an inheritance ('Erbfall'). This type of regulatory decision regarding control thresholds, mandatory offers, and exemptions falls under the scope of corporate control and regulatory compliance, but it is not a standard periodic report (10-K, IR) or a general press release (ER). Since it deals with specific regulatory actions concerning shareholdings and control, and given the options, it is most closely related to filings concerning capital structure changes or significant shareholdings, but the core subject is the regulatory decision itself. The document is a formal notice about a regulatory ruling concerning potential mandatory takeover obligations triggered by an inheritance. This is a specific regulatory event notification. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for specific, non-periodic regulatory notices that don't fit into the other defined categories like DIRS, MRQ, or CAP. However, since the document details the outcome of a formal application regarding control and potential takeover obligations (§ 35 WpÜG), it is a highly specific regulatory communication. In the context of German filings, these types of BaFin decisions are often disseminated as regulatory news. Since 'Regulatory Filings' (RNS) is the defined fallback for miscellaneous regulatory announcements, and this is a specific regulatory decision notice, RNS is the best fit among the provided codes, as it is not an ER, CT, or a standard financial report.
2024-11-25 German
RHON-KLINIKUM AG continues solid performance in the first nine months outlook confirmed
Earnings Release Classification · 100% confidence The document is a corporate news release dated November 7, 2024, detailing the company's performance for the 'first nine months of financial year 2024' (9M 2024). It provides key financial metrics (revenues, profit, EBITDA) for this nine-month period and confirms the outlook for the full year 2024. The presence of 'Quarter Results/9 Month figures' in the keywords and the comprehensive nature of the period covered (nine months) strongly indicate this is a report covering an interim period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it mentions the 'Quarterly Statement for Q3 2024 is published', the content itself summarizes the nine-month results, making it the report content rather than just an announcement of publication (RPA). 9M 2024
2024-11-07 English
Q3 statement / Q3 financial report 2024
Interim / Quarterly Report Classification · 95% confidence The document is a 'Quarterly Statement' for Q3 2024, which includes detailed financial tables such as the Consolidated Balance Sheet, Consolidated Income Statement, and Statement of Comprehensive Income. It provides a comprehensive analysis of business performance, net assets, and results of operations. Although it explicitly states it is not an 'interim report' under IAS 34 (a common disclaimer for quarterly statements in Germany), it contains substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR) within the provided classification schema. 9M 2024
2024-11-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.